900120 — CXI Healthcare Technology Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapValue Trap

Annual income statement for CXI Healthcare Technology, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	373	610	545	377	377
Cost of Revenue
Gross Profit	-67.3	127	153	149	162
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	964	583	511	340	274
Operating Profit	-590	26.4	33.9	36.7	102
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-580	29.7	32.2	39.6	159
Provision for Income Taxes
Net Income After Taxes	-580	29.7	32.2	39.6	159
Minority Interest
Net Income Before Extraordinary Items
Net Income	-579	29.7	32.2	39.6	159
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-579	29.7	31.8	39.6	159
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3.2	0.267	0.28	0.249	0.613
Dividends per Share